Tesmilifene in Combination With Docetaxel in the Treatment of Metastatic Breast Cancer

Summary

This is a Phase II study designed to evaluate whether the co-administration of a fixed dose of tesmilifene and a standard regimen of docetaxel alters the plasma pharmacokinetics of docetaxel. This study will also assess the safety and efficacy of the tesmilifene/docetaxel combination in metastatic breast cancer patients.

Timeline

Start

2006-06

Primary completion

—

Completion

—

Drugs

Indications